Assessment of Customized 3D Zirconium Versus Titanium Mesh for Anterior Maxillary Ridge Augmentation With Delayed Implant Placement
NCT ID: NCT06933030
Last Updated: 2025-04-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
20 participants
INTERVENTIONAL
2024-09-01
2026-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Short Implant Versus Crestal Standard Length Implant to Retain Class 1 Removable Partial Denture.
NCT06666595
The Evaluation of Facial Bone Changes After Early Implant Placement Protocols "Clinically and Radiographically".
NCT06165913
Stability of Patient-specific Root-analogue Implants and Conventional Root-form Implants for Treating Non-restorable Single-rooted Maxillary Teeth
NCT03689933
Evaluation of Using Patient Specific Zirconium Dioxide Implant Versus Patient Specific Titanium Implant in Treatment of Chronic Condylar Dislocation
NCT05377593
Implant-Abutment Interface Design on Bone and Soft Tissue Levels Around Implants Placed Using Different Transcrestal Sinus Floor Elevation
NCT02953392
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
\- Ten sites of anterior maxillary ridge atrophy will be treated by titanium mesh with bone graft with delayed implant placement.
Group II (tested group):
\- Ten sites anterior maxillary ridge atrophy will be treated by zirconium mesh with bone graft with delayed implant placement.
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group I (controlled group): -
Group I (controlled group):
\- Ten sites of anterior maxillary ridge atrophy will be treated by titanium mesh with bone graft with delayed implant placement.
titanium mesh with bone graft with delayed implant placement.
titanium mesh with bone graft with delayed implant placement.
Group II (tested group):
Group II (tested group):
\- Ten sites anterior maxillary ridge atrophy will be treated by zirconium mesh with bone graft with delayed implant placement.
zirconium mesh with bone graft with delayed implant placement.
zirconium mesh with bone graft with delayed implant placement.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
titanium mesh with bone graft with delayed implant placement.
titanium mesh with bone graft with delayed implant placement.
zirconium mesh with bone graft with delayed implant placement.
zirconium mesh with bone graft with delayed implant placement.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patient with anterior maxillary alveolar ridge deficiency (horizontal, vertical or combined defects) less than 2 mm in width or less than 6 mm in height - measured from the alveolar crest to the basal bone in order to be enrolled in this study. (56)
3. Adequate zone of keratinized gingiva at minimum 3mms.
4. Patient with sufficient inter-arch space for future dental rehabilitation.
5. Subjects who are not on any medication known to interfere with periodontal tissue health or healing within 6 months of the study.
Exclusion Criteria
2. Patients with deleterious habits like the use of tobacco chewing or smoking ones.
3. History of previous periodontal surgical treatment of the involved sites.
4. Presence of malocclusion and pathologic movement of teeth in involved sites.
5. Patient not willing to give consent for the study and poor plaque control.(57)
6. Pregnant or nursing mothers.
7. Patients with acute odontogenic infection.
20 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Mostafa Alhashash
ASSISTANT LECTURER
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tanta university
Tanta, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OMPDR7-242235
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.